BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 27789332)

  • 21. G-CSF, the guardian of granulopoiesis.
    Mehta HM; Corey SJ
    Semin Immunol; 2021 Apr; 54():101515. PubMed ID: 34772606
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Severe congenital neutropenia and chronic neutrophilic leukemia: an intriguing molecular connection unveiled by oncogenic mutations in CSF3R.
    Touw IP; Beekman R
    Haematologica; 2013 Oct; 98(10):1490-2. PubMed ID: 24091926
    [No Abstract]   [Full Text] [Related]  

  • 23. Granulocyte colony-stimulating factor and its receptor in normal myeloid cell development, leukemia and related blood cell disorders.
    Touw IP; van de Geijn GJ
    Front Biosci; 2007 Jan; 12():800-15. PubMed ID: 17127321
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Screening for G-CSF receptor mutations in patients with secondary myeloid or lymphoid transformation of severe congenital neutropenia. A report from the French neutropenia register.
    Cassinat B; Bellanné-Chantelot C; Notz-Carrère A; Menot ML; Vaury C; Micheau M; Bader-Meunier B; Perel Y; Leblanc T; Donadieu J; Chomienne C
    Leukemia; 2004 Sep; 18(9):1553-5. PubMed ID: 15284863
    [No Abstract]   [Full Text] [Related]  

  • 25. Granulocyte colony-stimulating factor (G-CSF) production and G-CSF receptor structure in patients with congenital neutropenia.
    Guba SC; Sartor CA; Hutchinson R; Boxer LA; Emerson SG
    Blood; 1994 Mar; 83(6):1486-92. PubMed ID: 7510142
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sequential gain of mutations in severe congenital neutropenia progressing to acute myeloid leukemia.
    Beekman R; Valkhof MG; Sanders MA; van Strien PM; Haanstra JR; Broeders L; Geertsma-Kleinekoort WM; Veerman AJ; Valk PJ; Verhaak RG; Löwenberg B; Touw IP
    Blood; 2012 May; 119(22):5071-7. PubMed ID: 22371884
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical relevance of point mutations in the cytoplasmic domain of the granulocyte colony-stimulating factor receptor gene in patients with severe congenital neutropenia.
    Tidow N; Pilz C; Teichmann B; Müller-Brechlin A; Germeshausen M; Kasper B; Rauprich P; Sykora KW; Welte K
    Blood; 1997 Apr; 89(7):2369-75. PubMed ID: 9116280
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CSF3R is mutated in chronic neutrophilic leukemia and atypical CML.
    Cancer Discov; 2013 Jul; 3(7):OF23. PubMed ID: 23847367
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A novel mutation in the juxtamembrane intracellular sequence of the granulocyte colony-stimulating factor (G-CSF) receptor gene in a patient with severe congenital neutropenia augments GCSF proliferation activity but not through the MAP kinase cascade.
    Yokoyama T; Okamura S; Asano Y; Kamezaki K; Numata A; Kakumitsu H; Shide K; Nakashima H; Taisuke K; Sekine Y; Mizuno Y; Okamura J; Matsuda T; Harada M; Yoshiyuki N; Shimoda K
    Int J Hematol; 2005 Jul; 82(1):28-34. PubMed ID: 16229088
    [TBL] [Abstract][Full Text] [Related]  

  • 30. G-CSF receptor mutations in patients with congenital neutropenia.
    Germeshausen M; Skokowa J; Ballmaier M; Zeidler C; Welte K
    Curr Opin Hematol; 2008 Jul; 15(4):332-7. PubMed ID: 18536571
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The carboxyl terminus of the granulocyte colony-stimulating factor receptor, truncated in patients with severe congenital neutropenia/acute myeloid leukemia, is required for SH2-containing phosphatase-1 suppression of Stat activation.
    Dong F; Qiu Y; Yi T; Touw IP; Larner AC
    J Immunol; 2001 Dec; 167(11):6447-52. PubMed ID: 11714811
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Granulocyte colony-stimulating factor receptor signaling defects from neutropenia to leukemia.
    Corey SJ; Zhu QS
    Isr Med Assoc J; 2002 Nov; 4(11):1032-4. PubMed ID: 12489499
    [No Abstract]   [Full Text] [Related]  

  • 33. Prevalence of a new auto-activating colony stimulating factor 3 receptor mutation (CSF3R-T595I) in acute myeloid leukemia and severe congenital neutropenia.
    Beekman R; Valkhof M; van Strien P; Valk PJ; Touw IP
    Haematologica; 2013 May; 98(5):e62-3. PubMed ID: 23508011
    [No Abstract]   [Full Text] [Related]  

  • 34. [G-CSF and Its Receptor in Hematonosis].
    Zhao SQ; Li JM
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2015 Jun; 23(3):871-7. PubMed ID: 26117053
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Game of clones: the genomic evolution of severe congenital neutropenia.
    Touw IP
    Hematology Am Soc Hematol Educ Program; 2015; 2015():1-7. PubMed ID: 26637693
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The new genetics of chronic neutrophilic leukemia and atypical CML: implications for diagnosis and treatment.
    Gotlib J; Maxson JE; George TI; Tyner JW
    Blood; 2013 Sep; 122(10):1707-11. PubMed ID: 23896413
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Increased granulocyte colony-stimulating factor responsiveness but normal resting granulopoiesis in mice carrying a targeted granulocyte colony-stimulating factor receptor mutation derived from a patient with severe congenital neutropenia.
    McLemore ML; Poursine-Laurent J; Link DC
    J Clin Invest; 1998 Aug; 102(3):483-92. PubMed ID: 9691084
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Granulocyte colony-stimulating factor receptor: stimulating granulopoiesis and much more.
    Liongue C; Wright C; Russell AP; Ward AC
    Int J Biochem Cell Biol; 2009 Dec; 41(12):2372-5. PubMed ID: 19699815
    [TBL] [Abstract][Full Text] [Related]  

  • 39. G-CSF receptor (CSF3R) mutations in X-linked neutropenia evolving to acute myeloid leukemia or myelodysplasia.
    Beel K; Vandenberghe P
    Haematologica; 2009 Oct; 94(10):1449-52. PubMed ID: 19794089
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Malignant Transformation Involving
    Olofsen PA; Fatrai S; van Strien PMH; Obenauer JC; de Looper HWJ; Hoogenboezem RM; Erpelinck-Verschueren CAJ; Vermeulen MPWM; Roovers O; Haferlach T; Jansen JH; Ghazvini M; Bindels EMJ; Schneider RK; de Pater EM; Touw IP
    Cell Rep Med; 2020 Aug; 1(5):100074. PubMed ID: 33205068
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.